Your browser's JavaScript is disabled.

To properly view the content on this page, please enable JavaScript.

Publications

Non-clinical Imetelstat: MF

All Publications

Telomerase-targeted therapies in myeloid malignancies

Clinical Imetelstat: MDS Imetelstat Non-clinical Imetelstat Non-clinical Imetelstat: MF

Blood Advances 2023

Waksal, et. al.

The telomerase inhibitor imetelstat differentially targets JAK2V617F- versus CALR-mutant Myeloproliferative Neoplasm cells and inhibits JAK-STAT signaling

Imetelstat Non-clinical Imetelstat: MF

Chatain, et. al.

[facetwp facet="publication_load_more"]